SCHEMBL984500

SCHEMBL984500

COCCNC(=O)[C@H]1CC[C@H](NC(=O)c2c[nH]c3c(-c4cc(F)ccc4OCC4CC4)ncnc23)CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.40
PDE4A P27815 2/20 0.36
PDE4B Q07343 2/20 0.36
PDE4C Q08493 2/20 0.36
PDE4D Q08499 2/20 0.36
BRD4 O60885 1/20 0.36
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
CDK2 P24941 4/20 0.35
IKBKE Q14164 2/20 0.35
AURKB Q96GD4 2/20 0.35
TBK1 Q9UHD2 2/20 0.35
CDK9 P50750 3/20 0.34
CDK1 P06493 2/20 0.34
CDK3 Q00526 2/20 0.34
CDK5 Q00535 2/20 0.34
GSK3A P49840 1/20 0.34
GSK3B P49841 1/20 0.34
CCNT1 O60563 1/20 0.34
CCNB1 P14635 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL981978 0.92 NPY5R (0.38) BRD4KMT2ACDK2CDK9CDK1
SCHEMBL984334 0.88 BTK (0.39) NPC1BRD4KMT2ACDK9CCNT1
SCHEMBL984898 0.88 GRIN1 (0.40) NPC1BRD4MEN1KMT2AGRIN1
SCHEMBL984446 0.88 BTK (0.40) BRD4KMT2ACDK2CDK9CDK1
SCHEMBL981589 0.87 MTNR1A (0.39) NPC1PDE4APDE4BPDE4CPDE4D
SCHEMBL985596 0.86 SMYD3 (0.41) BRD4KMT2AGRIN1GRIN2BALDH1A1
SCHEMBL983050 0.86 BRD4 (0.37) NPC1BRD4KMT2ACDK9CCNT1
Hydrochloric Acid SCHEMBL985170 0.86 SMYD3 (0.40) BRD4KMT2AGRIN1GRIN2BALDH1A1
Hydrochloric Acid SCHEMBL985798 0.85 ACKR3 (0.38) BRD4KMT2ACDK9CCNT1ALDH1A1
SCHEMBL983632 0.84 BTK (0.39) BRD4KMT2ACDK9CCNT1JAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110021479-A1 PYRROLOPYRIMIDINECARBOXAMIDES NYCOMED GMBH (DE) 2011-01-27 US claimed
US-20110021479-A1 PYRROLOPYRIMIDINECARBOXAMIDES NYCOMED GMBH (DE) 2011-01-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110021479-A1 PYRROLOPYRIMIDINECARBOXAMIDES PDE5A, PDE3A, PDE2A NPC1 4489/4885PDE4A 6/4885PDE4B 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.